Nebius Q1: Too Green? Too Fast? 7x Since I first Covered It, 2x in 40 days—Is It Still Cheap? (NBIS)
Nebius Q1: Too Green? Too Fast? 7x Since I first Covered It, 2x in 40 days—Is It Still Cheap? (NBIS)
YouTube8 min 3 sec
Watch on YouTube
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights

Investors should exercise extreme caution with Nebius Group (NBIS) following its 700% rally, as the current "casino-like" price action suggests the stock has decoupled from its fundamentals. While the company remains fundamentally strong with a massive 1.2 gigawatt AI site expansion, a looming capital raise to fund infrastructure could trigger a price correction or share dilution. Existing shareholders should consider trimming positions or selling if the parabolic move continues, especially as the stock becomes an uncomfortably large portion of a portfolio. For those seeking better relative value, Hims & Hers Health (HIMS) presents a potential opportunity, as the stock recently dropped 20% despite raising financial guidance. Overall, the AI Infrastructure sector remains highly volatile, and investors should wait for cooling-off periods rather than chasing violent "catch-up" rallies.

Detailed Analysis

Nebius Group (NBIS)

Nebius has experienced an extraordinary run, with the stock price increasing 700% (7x) over the last 11 months, moving from $36 to $208. • Recent price action is described as "wild" and "casino-like," with the stock surging 125% in just 43 days. • Q1 Earnings Highlights: • The company reconfirmed its existing guidance but did not raise it. • Announced a new 1.2 gigawatt AI site acquisition and a new site in Finland. • Business execution remains strong, following previous major deals with Meta (a $27 billion deal), Microsoft, and Nvidia. • Valuation Metrics: • The analyst uses a specific metric: EV/GP/RG (Enterprise Value over Gross Profit over Revenue Growth). • The current valuation is 0.18, which is still considered "cheap" by the analyst, though significantly higher than the 0.05 level seen previously.

Takeaways

Exercise Caution on Entry: The analyst warns that buying at current levels feels like "chasing" a move that has decoupled from the underlying business changes. • Monitor for Capital Raises: There is a strong expectation that Nebius will need to raise more capital soon to finance its massive infrastructure investments and growth. This could lead to stock dilution or a price correction. • Market Sentiment vs. Fundamentals: The recent 125% surge is attributed more to "market flows" and "playing catch-up" from being undervalued in Q1, rather than new fundamental breakthroughs. • Potential Sell Signal: For existing investors, the analyst suggests that if the parabolic move continues without a cooling-off period, it may be time to trim positions or sell, especially as it becomes an "uncomfortably large" portion of a portfolio.


AI Infrastructure & Data Centers

• The sector is seeing massive scale, evidenced by Nebius adding 1.2 gigawatts of capacity. • High CapEx (Capital Expenditure) is a requirement in this sector; companies must spend heavily on hardware and sites to compete.

Takeaways

Sector Volatility: Investors should be prepared for extreme volatility. The analyst notes that the market often fluctuates between "freaking out" over high spending (CapEx) and cheering for growth. • Lagged Market Reactions: Significant news (like the Meta deal) may not be priced in immediately, leading to delayed "catch-up" rallies that can be violent and fast.


Hims & Hers Health, Inc. (HIMS)

• Mentioned briefly as a point of comparison regarding market irrationality. • The company increased its guidance but saw its stock price drop 20%, contrasting sharply with Nebius, which did not raise guidance but saw its stock double.

Takeaways

Relative Value Opportunity: The mention suggests that while the market is currently obsessed with AI infrastructure (like Nebius), other high-performing companies with improving fundamentals (like Hims) are being punished, potentially creating a divergence in value.

Ask about this postAnswers are grounded in this post's content.
Video Description
Join Patreon for Exclusive Perks: https://www.patreon.com/btdenominator In this no financial advice video, I cover Nebius stock Q1 earnings and the market's wild reaction to it, and I ask if it's too green too fast, and whether the stock is still looking too cheap on a EV/GP/RG number! No Investment Advice! As always, this video is NOT investment advice, and none of the contents should be construed as such. I do not make short-term or long-term price predictions for any stock investment, and all words spoken in this video are for entertainment purposes ONLY .
About Beat The Denominator
Beat The Denominator

Beat The Denominator

By @BeatTheDenominator